James Hartley. 2026. “Aberrant Splicing Factor SF3A2 As a Prognostic Biomarker and Therapeutic Target in Colorectal Cancer: Interplay With Immune Infiltration and Natural Product Intervention”. International Journal of Medical Science and Dental Health 12 (09): 176-81. https://doi.org/10.55640/ijmsdh-12-09-20.